BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pereira J, Accatino L, Alfaro J, Brahm J, Hidalgo P, Mezzano D. Platelet autoantibodies in patients with chronic liver disease. Am J Hematol. 1995;50:173-178. [PMID: 7485078 DOI: 10.1002/ajh.2830500305] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Maan R, de Knegt RJ, Veldt BJ. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies. Drugs 2015;75:1981-92. [PMID: 26501978 DOI: 10.1007/s40265-015-0480-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
2 Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 107] [Cited by in F6Publishing: 84] [Article Influence: 10.7] [Reference Citation Analysis]
3 Gangireddy VG, Kanneganti PC, Sridhar S, Talla S, Coleman T. Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol. 2014;28:558-564. [PMID: 25222481 DOI: 10.1155/2014/532191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
4 Weksler BB. Review article: the pathophysiology of th-rombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther. 2007;26 Suppl 1:13-19. [PMID: 17958515 DOI: 10.1111/j.1365-2036.2007.03512.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
5 Saab S, Brown RS Jr. Management of Thrombocytopenia in Patients with Chronic Liver Disease. Dig Dis Sci. 2019;64:2757-2768. [PMID: 31011942 DOI: 10.1007/s10620-019-05615-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
6 Giannini EG, Savarino V. Thrombocytopenia in liver disease: . Current Opinion in Hematology 2008;15:473-80. [DOI: 10.1097/moh.0b013e32830a9746] [Cited by in Crossref: 62] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
7 Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 13.2] [Reference Citation Analysis]
8 Chen YC, Tseng CW, Tseng KC. Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents. Medicine (Baltimore) 2020;99:e20156. [PMID: 32384505 DOI: 10.1097/MD.0000000000020156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006;12:1205-10. [PMID: 16534872 DOI: 10.3748/wjg.v12.i8.1205] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin. 2005;21:563-587. [PMID: 15992673 DOI: 10.1016/j.ccc.2005.03.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
11 Khemichian S, Terrault NA. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease. Semin Thromb Hemost. 2020;46:682-692. [PMID: 32820479 DOI: 10.1055/s-0040-1715451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
12 Samuel H, Nardi M, Karpatkin M, Hart D, Belmont M, Karpatkin S. Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements. Br J Haematol. 1999;105:1086-1091. [PMID: 10554825 DOI: 10.1046/j.1365-2141.1999.01469.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
13 Lambert MP. Platelets in liver and renal disease. Hematology Am Soc Hematol Educ Program. 2016;2016:251-255. [PMID: 27913488 DOI: 10.1182/asheducation-2016.1.251] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
14 Giannini E, Borro P, Botta F, Fumagalli A, Malfatti F, Podestà E, Romagnoli P, Testa E, Chiarbonello B, Polegato S. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol. 2002;37:572-577. [PMID: 12399221 DOI: 10.1016/s0168-8278(02)00274-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
15 Abdel-razik A, Mousa N, Zakaria S, Elhelaly R, Elzehery R, Zalata K, Awad M, Eldeeb AA, Abdelsalam M. New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume. European Journal of Gastroenterology & Hepatology 2017;29:1373-9. [DOI: 10.1097/meg.0000000000000982] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Sheikh MY, Raoufi R, Atla PR, Riaz M, Oberer C, Moffett MJ. Prevalence of cirrhosis in patients with thrombocytopenia who receive bone marrow biopsy. Saudi J Gastroenterol 2012;18:257-62. [PMID: 22824769 DOI: 10.4103/1319-3767.98431] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Wada N, Uojima H, Satoh T, Okina S, Iwasaki S, Shao X, Takiguchi H, Arase Y, Itokawa N, Atsukawa M, Miyazaki K, Hidaka H, Kako M, Kagawa T, Iwakiri K, Horie R, Suzuki T, Koizumi W. Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease. Dig Dis 2021;39:234-42. [PMID: 32759604 DOI: 10.1159/000510692] [Reference Citation Analysis]
18 Nwokediuko SC, Ibegbulam O. Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease. Gastroenterology Res 2009;2:344-9. [PMID: 27990204 DOI: 10.4021/gr2009.12.1329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Chong BH, Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura. Seminars in Hematology 2000;37:249-60. [DOI: 10.1016/s0037-1963(00)90103-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
20 Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr 2009;52:595-9. [PMID: 19734800 DOI: 10.1097/QAI.0b013e3181b79aff] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
21 Hadziyannis SJ. Skin diseases associated with hepatitis C virus infection. J Eur Acad Dermatol Venereol. 1998;10:12-21. [PMID: 9552752 DOI: 10.1111/j.1468-3083.1998.tb00922.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
22 Rawi S, Wu GY. Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review. J Clin Transl Hepatol 2020;8:184-91. [PMID: 32832399 DOI: 10.14218/JCTH.2020.00007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Dou J, Lou Y, Wu J, Lu Y, Jin Y. Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction. Platelets. 2014;25:399-404. [PMID: 24047408 DOI: 10.3109/09537104.2013.832742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
24 Bano S, Qureshi J, Raza A, Zafar Hashmi K. Thrombocytopenia as a Clinical Manifestation of Hepatitis C Among Patients With a Positive Anti-HCV Test. Int J Infect 2016;3. [DOI: 10.17795/iji-35094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
25 Ando M, Iwamoto Y, Suda A, Tsuchiya K, Nihei H. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood 2001;97:915-21. [DOI: 10.1182/blood.v97.4.915] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
26 McMurry HS, Jou J, Shatzel J. The hemostatic and thrombotic complications of liver disease. Eur J Haematol 2021. [PMID: 34258797 DOI: 10.1111/ejh.13688] [Reference Citation Analysis]
27 Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R, Cesaro G, Ragone E, Durante Mangoni E, Ruggiero G. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol. 2001;113:590-595. [PMID: 11380442 DOI: 10.1046/j.1365-2141.2001.02824.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 5.7] [Reference Citation Analysis]
28 Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D. Review article: Blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017-1029. [PMID: 18331464 DOI: 10.1111/j.1365-2036.2008.03674.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 83] [Article Influence: 7.8] [Reference Citation Analysis]
29 Ghalib R, Levine C, Hassan M, McClelland T, Goss J, Stribling R, Seu P, Patt YZ. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis. Hepatology. 2003;37:1165-1171. [PMID: 12717398 DOI: 10.1053/jhep.2003.50160] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
30 Afdhal N, Mchutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R. Thrombocytopenia associated with chronic liver disease. Journal of Hepatology 2008;48:1000-7. [DOI: 10.1016/j.jhep.2008.03.009] [Cited by in Crossref: 328] [Cited by in F6Publishing: 254] [Article Influence: 25.2] [Reference Citation Analysis]
31 Kavanagh C, Shaw S, Webster CR. Coagulation in hepatobiliary disease. J Vet Emerg Crit Care (San Antonio). 2011;21:589-604. [PMID: 22316251 DOI: 10.1111/j.1476-4431.2011.00691.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
32 Abdela J. Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag. Clin Med Insights Blood Disord 2019;12:1179545X19875105. [PMID: 31673229 DOI: 10.1177/1179545X19875105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39-50. [PMID: 27186144 DOI: 10.2147/hmer.s74612] [Cited by in Crossref: 18] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
34 Kargili A, Cipil H, Karakurt F, Kasapoglu B, Koca C, Aydn M, Uysal S, İkizek M, Uz E, Balcik OS, Kosar A. Hemostatic alterations in fatty liver disease: . Blood Coagulation & Fibrinolysis 2010;21:325-7. [DOI: 10.1097/mbc.0b013e328337b3f8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
35 Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280-287. [PMID: 12127437 DOI: 10.1016/s0168-8278(02)00199-x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
36 Sanjo A, Satoi J, Ohnishi A, Maruno J, Fukata M, Suzuki N. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol. 2003;18:638-644. [PMID: 12753144 DOI: 10.1046/j.1440-1746.2003.03026.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
37 Wadenvik H, Stockelberg D, Hou M. Platelet proteins as autoantibody targets in idiopathic thrombocytopenic purpura. Acta Paediatr Suppl 1998;424:26-36. [PMID: 9736215 DOI: 10.1111/j.1651-2227.1998.tb01230.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
38 Rauber P, Lammert F, Grotemeyer K, Appenrodt B. Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study. PLoS One 2018;13:e0192271. [PMID: 29438423 DOI: 10.1371/journal.pone.0192271] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
39 Kee KM, Wang JH, Hung CH, Chen CH, Lee CM, Lu SN. Improvement of thrombocytopenia in hepatitis C-related advanced fibrosis patients after sustained virological response. Dig Dis Sci 2013;58:556-61. [PMID: 23001404 DOI: 10.1007/s10620-012-2380-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
40 Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii H, Ikeda Y, Kuwana M. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatology. 2003;37:1267-1276. [PMID: 12774004 DOI: 10.1053/jhep.2003.50209] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 4.2] [Reference Citation Analysis]
41 Lin KH, Hsu PI, Yu HC, Lin CK, Tsai WL, Chen WC, Chan HH, Lai KH. Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts. BMC Gastroenterol 2012;12:7. [PMID: 22257364 DOI: 10.1186/1471-230X-12-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
42 Lv Y, Yee Lau W, Wu H, Han X, Gong X, Liu N, Yue J, Li Q, Li Y, Deng J. Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly. Exp Biol Med (Maywood). 2017;242:744-749. [PMID: 28299974 DOI: 10.1177/1535370217693113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
43 Munoz SJ, Stravitz RT, Gabriel DA. Coagulopathy of acute liver failure. Clin Liver Dis. 2009;13:95-107. [PMID: 19150314 DOI: 10.1016/j.cld.2008.10.001] [Cited by in Crossref: 84] [Cited by in F6Publishing: 48] [Article Influence: 7.0] [Reference Citation Analysis]
44 Lin YY, Hu CT, Sun DS, Lien TS, Chang HH. Thioacetamide-induced liver damage and thrombocytopenia is associated with induction of antiplatelet autoantibody in mice. Sci Rep 2019;9:17497. [PMID: 31767905 DOI: 10.1038/s41598-019-53977-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
45 Lv Y, Lau WY, Li Y, Deng J, Han X, Gong X, Liu N, Wu H. Hypersplenism: History and current status. Exp Ther Med 2016;12:2377-82. [PMID: 27703501 DOI: 10.3892/etm.2016.3683] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
46 Dusheiko G. Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C. Clin Liver Dis 2009;13:487-501. [PMID: 19628164 DOI: 10.1016/j.cld.2009.05.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]